ATE263576T1 - Prostaglandine und benzylalcohol enthaltende lösung - Google Patents
Prostaglandine und benzylalcohol enthaltende lösungInfo
- Publication number
- ATE263576T1 ATE263576T1 AT99935286T AT99935286T ATE263576T1 AT E263576 T1 ATE263576 T1 AT E263576T1 AT 99935286 T AT99935286 T AT 99935286T AT 99935286 T AT99935286 T AT 99935286T AT E263576 T1 ATE263576 T1 AT E263576T1
- Authority
- AT
- Austria
- Prior art keywords
- benzyl alcohol
- solution containing
- containing prostaglandins
- prostaglandins
- new formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/094,985 US6187818B1 (en) | 1998-06-17 | 1998-06-17 | Prostaglandins formulation and process |
| PCT/US1999/011808 WO1999065527A1 (en) | 1998-06-17 | 1999-06-08 | Solution comprising prostaglandins and benzyl alcohol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE263576T1 true ATE263576T1 (de) | 2004-04-15 |
Family
ID=22248341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99935286T ATE263576T1 (de) | 1998-06-17 | 1999-06-08 | Prostaglandine und benzylalcohol enthaltende lösung |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6187818B1 (de) |
| EP (1) | EP1085907B1 (de) |
| JP (1) | JP4472175B2 (de) |
| KR (1) | KR100608176B1 (de) |
| CN (1) | CN1188170C (de) |
| AT (1) | ATE263576T1 (de) |
| AU (1) | AU752047B2 (de) |
| CA (1) | CA2331284C (de) |
| DE (1) | DE69916266T2 (de) |
| DK (1) | DK1085907T3 (de) |
| ES (1) | ES2219036T3 (de) |
| HK (1) | HK1036413A1 (de) |
| NZ (1) | NZ508947A (de) |
| PT (1) | PT1085907E (de) |
| WO (1) | WO1999065527A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU766163B2 (en) | 1999-03-05 | 2003-10-09 | Duke University | C16 unsaturated fp-selective prostaglandins analogs |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| CN108078998B (zh) * | 2017-11-23 | 2018-09-21 | 宁波三生生物科技有限公司 | 一种氨基丁三醇前列腺素F2α注射液及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3885041A (en) * | 1970-12-28 | 1975-05-20 | Searle & Co | Antiinflammatory use of prostaglandins |
| US3917864A (en) | 1973-02-12 | 1975-11-04 | Sultanali M M Karim | Use of prostaglandins E and F for induction of labor |
| US3903297A (en) | 1973-11-01 | 1975-09-02 | Upjohn Co | Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs |
| EP0268066A3 (de) | 1986-10-17 | 1990-07-11 | Syntex (U.S.A.) Inc. | Fertilitäts-Kontrolle und Uterin-Therapie bei Hunden mit LHRH-Antagonisten |
| AR002194A1 (es) | 1997-03-17 | 1998-01-07 | Sanchez Reynaldo Alemany | Instrumento computarizado para el analisis del movimiento. |
-
1998
- 1998-06-17 US US09/094,985 patent/US6187818B1/en not_active Expired - Lifetime
-
1999
- 1999-06-08 DE DE69916266T patent/DE69916266T2/de not_active Expired - Lifetime
- 1999-06-08 DK DK99935286T patent/DK1085907T3/da active
- 1999-06-08 WO PCT/US1999/011808 patent/WO1999065527A1/en active IP Right Grant
- 1999-06-08 AT AT99935286T patent/ATE263576T1/de active
- 1999-06-08 JP JP2000554404A patent/JP4472175B2/ja not_active Expired - Lifetime
- 1999-06-08 NZ NZ508947A patent/NZ508947A/en not_active IP Right Cessation
- 1999-06-08 ES ES99935286T patent/ES2219036T3/es not_active Expired - Lifetime
- 1999-06-08 KR KR1020007014321A patent/KR100608176B1/ko not_active IP Right Cessation
- 1999-06-08 EP EP99935286A patent/EP1085907B1/de not_active Expired - Lifetime
- 1999-06-08 AU AU50796/99A patent/AU752047B2/en not_active Expired
- 1999-06-08 CN CNB998062677A patent/CN1188170C/zh not_active Expired - Lifetime
- 1999-06-08 PT PT99935286T patent/PT1085907E/pt unknown
- 1999-06-08 CA CA002331284A patent/CA2331284C/en not_active Expired - Lifetime
-
2001
- 2001-10-24 HK HK01107418A patent/HK1036413A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU5079699A (en) | 2000-01-05 |
| EP1085907B1 (de) | 2004-04-07 |
| CN1301178A (zh) | 2001-06-27 |
| CA2331284A1 (en) | 1999-12-23 |
| JP2002518348A (ja) | 2002-06-25 |
| WO1999065527A1 (en) | 1999-12-23 |
| KR20010052944A (ko) | 2001-06-25 |
| KR100608176B1 (ko) | 2006-08-04 |
| CA2331284C (en) | 2009-09-22 |
| PT1085907E (pt) | 2004-08-31 |
| HK1036413A1 (en) | 2002-01-04 |
| DE69916266D1 (de) | 2004-05-13 |
| DK1085907T3 (da) | 2004-06-21 |
| DE69916266T2 (de) | 2005-03-10 |
| ES2219036T3 (es) | 2004-11-16 |
| JP4472175B2 (ja) | 2010-06-02 |
| AU752047B2 (en) | 2002-09-05 |
| US6187818B1 (en) | 2001-02-13 |
| EP1085907A1 (de) | 2001-03-28 |
| NZ508947A (en) | 2003-05-30 |
| CN1188170C (zh) | 2005-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20054324L (no) | Anvendelse av ranolazin og minst ett pH-avhengig bindemiddel for fremstilling av ranolazinpreparater med depotvirkning | |
| NO304261B1 (no) | Preparat omfattende en lipofil forbindelse | |
| PL319603A1 (en) | Stable aqueous alpha interferon preparations | |
| NZ332625A (en) | Concentrated antibody preparation containing greater than 100 mg/ml of the antibody | |
| BR9912694A (pt) | Composto para preparar medicamento de administração pulmonar | |
| DK0871476T3 (da) | Tørret blodfaktorpræparat indeholdende trehalose | |
| ATE201988T1 (de) | Transdermale, orale und intravenöse zubereitungen von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4- benzochinon | |
| SE9800729D0 (sv) | New topical formulation I | |
| ATE263576T1 (de) | Prostaglandine und benzylalcohol enthaltende lösung | |
| FI910112A (fi) | Preparat foer lokalt bruk. | |
| IT1260155B (it) | Uso terapeutico della fosforil-l-serina-n-acil-sfingosina | |
| HUP9902415A2 (hu) | Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására | |
| DK0647129T3 (da) | Præparat til topisk anvendelse | |
| AU618896B2 (en) | Stable solutions of rebeccamycin analog and preparation thereof | |
| AU2001258859A1 (en) | Pralmorelin-containing nasal drop preparations | |
| IT1250658B (it) | Composizioni farmaceutiche utilizzabili in gastroenterologia | |
| FR2567756B1 (fr) | Nouvelles compositions pharmaceutiques contenant comme ingredient actif l'acetyl-10 triacetoxy-1,8,9 anthracene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1085907 Country of ref document: EP |